Treatment Response to Mavacamten in Patients With Obstructive Hypertrophic Cardiomyopathy: 96-Week Results From the EXPLORER Cohort of the MAVA-Long-Term Extension Cardiac Magnetic Resonance Imaging Substudy

By afschroeder • September 23, 2025

Saberi S, Kramer CM, Oręziak A, Masri A, Barriales-Villa R, Abraham TP, Lakdawala NK, Wang A, Choudhury L, Rader F, Havakuk O, Stendahl JC, Cardim N, Seidler T, Sherrid M, Hegde SM, Kwong RY, Jerosch-Herold M, Balaratnam G, Kurio G, Fox S, Olivotto I, Owens A. Treatment Response to Mavacamten in Patients With Obstructive Hypertrophic Cardiomyopathy: 96-Week Results From the EXPLORER Cohort of the MAVA-Long-Term Extension Cardiac Magnetic Resonance Imaging Substudy. Circulation. 2025 Sep 23;152(12):905-908. doi: 10.1161/CIRCULATIONAHA.124.071188. Epub 2025 Sep 22. PMID: 40982583.

Tags: Cardiology/Epi, cardiomyopathies, cardiomyopathy, Cedars Sinai DoM, hypertrophic, Magnetic resonance imaging, Publications

Long-Term Survival in Liver Transplant Patients With Coronary Artery Disease: A Multi-Institutional Study

Wray CL, Scovotti JC, Tobis J, Honda HM, Planinsic R, Walia A, Findlay J, Wagener G, Cywinski JB, Olmos A, Markovic D, Hughes C, Humar[...]

Psychological and emotional drivers of atherosclerotic cardiovascular disease: Screening the brain to protect the heart

Atmani K, Vaseghi M. Psychological and emotional drivers of atherosclerotic cardiovascular disease: Screening the brain to protect the heart. Trends Cardiovasc Med. 2025 Nov 4:S1050-1738(25)00145-8.[...]

Cardiac resynchronisation therapy among adults with a systemic right ventricle: a multicentre experience

Fusco F, Scognamiglio G, Dellborg M, Dehghani P, Jameson SM, Kay WA, Cramer JW, Vonder Muhll I, Krieger EV, Rodriguez FH, Burchill LJ, Nicolarsen J,[...]